AstraZeneca Pharma India Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has announced the results of its postal ballot conducted between February 28 and March 29, 2026. Two ordinary resolutions were put to vote for approval of material related party transactions — one with AstraZeneca UK Limited and another with AstraZeneca AB, Sweden, both group entities. Both resolutions were passed by the non-related members with the requisite majority, receiving around 83% votes in favour (2,780,305 shares out of 3,347,401 valid votes for the first, and 2,780,598 for the second). A total of 297 members participated through remote e-voting, with 15,991 votes classified as invalid. The results and scrutinizer's report have been filed with the stock exchanges and uploaded on the company's website.
This is a routine compliance filing confirming shareholder approval for ongoing related party transactions within the AstraZeneca group. No material change to the business or shareholder value is expected from this announcement.